Nitric oxide and human thermal injury short term outcome

Burns

Volumn 24, Issue 3, 1998, Pages 207-212

  Caneira Da Silva, Manuel Do Rosário ^a   Mota Filipe, Helder ^a   Amaro Pinto, Rui Manuel ^a   Salaverría Timóteo De Carvalho, Maria Francisca ^a   Monteiro Godinho De Matos, Manuel Maria ^a   Cordeiro Ferreira, Acácio ^a   Gião Toscano Rico, José Manuel ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Nitric oxide; Outcome; Thermal injury

Indexed keywords

NITRATE; NITRIC OXIDE; NITRITE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; BODY SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LUNG BURN; MORTALITY; SEPSIS; STATISTICAL ANALYSIS; THERMAL INJURY; URINE LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BURNS; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; PROGNOSIS; TRAUMA SEVERITY INDICES;

EID: 0032078488     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(98)00014-X     Document Type: Article

References (47)

1. [1] Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
2. [2] Hibbs JB Jr, Westenfelder C, Taintor RR. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 1992; 89: 867-877.
3. [3] Katsuki S, Arnold W, Mittal C, Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 1977; 3: 23-35.
4. [4] Ignarro LJ, Buga GM, Wood KS, Byrs RE, Chauhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265-9269.
5. [5] Khan MT, Furchott RF. Similarities of behavior of nitric oxide (NO) and endothelium-derived relaxing factor in a perfusion cascade bioassay system. Fed Proc 1987; 46: 385
6. [6] Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
7. [7] Moncada S, Higgs A. The L-Arginine-Nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
8. [8] Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
9. [9] Knowles RG, Moncada S. Nitric oxide synthase in mammals. Biochem J 1994; 298: 249
10. [10] Nakane M, Schmith HHHW, Pollock JS, et al. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS 1993; Lett 316: 175
11. [11] Wood ER, Berger H Jr, Sherman PA, Lapetina EG. Hepatocytes and macrophages express an identical cytokine inducible nitric oxide synthase gene. Biochem Biophys Res Commun 1993; 191: 767
12. [12] Kuo PC, Schroeder RA. The emerging multifaceted roles of nitric oxide. Ann Surg 1995; 221: 200-235.
13. [13] Cho HJ, Xie Q, Calaycay J. Calmodulin is a subunit of a nitric oxide synthase from macrophages. J Exp Med 1992; 176: 599-604.
14. [14] Ward PA, Till GO. Pathophysiologic events related to thermal injury of skin. J Trauma 1990; 30: s75
15. [15] Wolf TA, Dasta JF. Use of nitric oxide synthase inhibitors as a novel treatment for septic shock. Ann Pharmacother 1995; 29: 36-46.
16. [16] Munoz-Fernandez MA, Fernandez MA, Fresno M. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-α and IFN-γ through a nitric oxide dependent mechanism. Immunol Lett 1992; 127: 179
17. [17] Stuehr DJ, Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985; 82: 7738-7742.
18. [18] Goode H, Howdle P, Walker B, Webster NR. Nitric oxide synthase activity is increased in patients with sepsis syndrome. Clin Sci 1995; 88: 131
19. [19] Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, Peitzman AB. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214: 621-626.
20. [20] Becker WK, Shippee RL, McManus AT, Manson AD Jr, Pruitt BA Jr. Kinetics of nitrogen oxide production following experimental thermal injury in rats. J Trauma 1993; 34: 855-862.
21. [21] Carter EA, Derojas-Walker R, Tamir S, Tannenbaum SR, Yu YM, Tompkins RG. Nitric oxide production in intensely and persistently increased in tissue by thermal injury. Biochem J 1994; 304: 201
22. [22] Preiser J-C, Reper P, Vlasselaer D, Vray B, Zhang H, Metz G, Vanderkelen A, Vicent J-L. Nitric oxide production is increased in patients after burn injury. J Trauma 1996; 40: 368-371.
23. [23] Gamelli RL, George M, Sharp-Pucci M, Dries DJ, Radisavljevic Z. Burn-induced nitric oxide release in humans. J Trauma 1995; 39: 869-877.
24. [24] Garcia NM, Horton JW, White J. The contribution of nitric oxide to postburn cardiac dysfunction. Circ Shock 1994; 40: 68. Abstract
25. [25] Bamberger T, Mansson I, Mathieu J, Chauvelot-Moachon L, Girou JP, Florentin I. Nitric oxide mediates the depression of lymphoproliferative responses following burn injury in rats. Biomed Pharmacother 1992; 46: 495
26. [26] Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal Biochem 1982; 126: 132
27. [27] Arturson G, Jonsson CE. Transcapillary transport after thermal injury. Scand J Plast Reconstr Surg 1979; 13: 29-38.
28. [28] Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol 1992; 262: H611-H615.
29. [29] Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989; 3: 2007-2018.
30. G-methyl-L-Arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172: 1132-1138.
31. [31] Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338: 8782
32. [32] Hotchkiss RS, Karl IE, Parker JL, Adams HR. Inhibition of NO synthesis in septic shock. Lancet 1992; 339: 434-435.
33. [33] Adams LB, Franzbiau SG, Vavrin Z, Hibbs JB Jr, Krahenbuhl JL. L-arginine dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. J Immunol 1991; 147: 1642-1646.
34. [34] Bekerman KP, Rogers HD, Corbett JA, Schreiber RD, McDaniel ML, Unanue ER. Release of oxide nitric during T-cell independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol 1993; 150: 888-895.
35. [35] Croen KD. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J Clin Invest 1993; 91: 2446-2452.
36. [36] Alspaugh JA, Granger DL. Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect Immun 1991; 59: 2291-2296.
37. [37] Rockett KA, Awburn MM, Aggarwal BB, Cowden WB, Clark IA. In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1: possible role in malaria. Infect Immun 1992; 60: 3725-3730.
38. [38] Stuehr DJ, Nathan CF. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989; 169: 1543-1545.
39. [39] Kwon NS, Stuehr DJ, Nathan CF. Inhibition of tumor cell ribonucleotide reductase by macrophage derived nitric oxide. J Exp Med 1991; 174: 761-768.
40. [40] Wink DA, Kasprzac KS, Maragos CM, Elespuru RK, Misra M, Dunams TM. Dna deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991; 254: 1001-1003.
41. [41] Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620
42. m-Amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 1992; 176: 1175-1182.
43. [43] Huan J, Han Y, Chen Y. Effects of thermal injury on production of nitric oxide in rat heart. Abstract. Chung Hua Wai Ko Tsa Chih 1995; 33: 568-570.
44. [44] Mellion BT, Ignarro LJ, Ohlstein EH. Evidence for the inhibitory role of the guanosine 3′:5′-monophosphate in ADP induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981; 57: 946-955.
45. [45] Eurenius K. Hematologic changes in burns. In: Artz PC, Moncrief JA, Pruit A Jr, editors. Burns a team approach. Philadelphia: Saunders 1979:132-42.
46. [46] Rees DD, Palmer RMJ, Schultz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101: 746-752.
47. G-monomethyl-L-Arginine. J Cardiovasc Pharmacol 1992; 20: S132-S134.